作者: S. Jonas , C. Benckert , A. Thelen , E. Lopez-Hänninen , T. Rösch
DOI: 10.1016/J.EJSO.2007.09.024
关键词:
摘要: In the therapy of hilar cholangiocarcinoma, most favorable survival rates over long-term are achieved by a surgical concept involving no-touch-technique, en-bloc-resection and wide tumor-free margins. Currently, these goals can be best our strategy to combine extended right hepatic resections principle portal vein resection. spite extending resectability patients with locally advanced tumors, formally curative could performed in 80% patients. The 5-year rate is 61%. Liver transplantation had been abandoned centers 1980s due poor overall results. Recently, neoadjuvant radiochemotherapy has reported result excellent figures at least subset suffering from cholangiocellular carcinoma arising primary sclerosing cholangitis (PSC). This protocol mainly proposed Mayo Clinic group reached those whom it applicable. A substantial drop out this regimen tumor progression or treatment related complications still problem.